WallStSmart

Akso Health Group ADR (AHG)vsSynergy CHC Corp. Common Stock (SNYR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Synergy CHC Corp. Common Stock generates 134% more annual revenue ($34.59M vs $14.78M). SNYR leads profitability with a 7.5% profit margin vs 0.0%. SNYR earns a higher WallStSmart Score of 45/100 (D).

AHG

Avoid

24

out of 100

Grade: F

Growth: 6.0Profit: 2.5Value: 5.0Quality: 7.5
Piotroski: 2/9Altman Z: 7.29

SNYR

Hold

45

out of 100

Grade: D

Growth: 4.3Profit: 6.0Value: 7.0Quality: 7.0
Piotroski: 4/9Altman Z: -0.45
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AHG.

SNYRUndervalued (+13.2%)

Margin of Safety

+13.2%

Fair Value

$1.90

Current Price

$1.17

$0.73 discount

UndervaluedFair: $1.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHG2 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
7.2910/10

Safe zone — low bankruptcy risk

SNYR2 strengths · Avg: 10.0/10
P/E RatioValuation
4.2x10/10

Attractively priced relative to earnings

Debt/EquityHealth
-3.0410/10

Conservative balance sheet, low leverage

Areas to Watch

AHG4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
4.2%4/10

4.2% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$807.33M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

SNYR4 concerns · Avg: 2.5/10
Market CapQuality
$13.16M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
7.5%3/10

7.5% margin — thin

Return on EquityProfitability
-3.6%2/10

ROE of -3.6% — below average capital efficiency

EPS GrowthGrowth
-90.6%2/10

Earnings declined 90.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : AHG

The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.

Bull Case : SNYR

The strongest argument for SNYR centers on P/E Ratio, Debt/Equity. Revenue growth of 12.4% demonstrates continued momentum.

Bear Case : AHG

The primary concerns for AHG are Revenue Growth, EPS Growth, Market Cap.

Bear Case : SNYR

The primary concerns for SNYR are Market Cap, Profit Margin, Return on Equity.

Key Dynamics to Monitor

SNYR carries more volatility with a beta of 1.27 — expect wider price swings.

SNYR is growing revenue faster at 12.4% — sustainability is the question.

AHG generates stronger free cash flow (3M), providing more financial flexibility.

Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SNYR scores higher overall (45/100 vs 24/100) and 12.4% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Akso Health Group ADR

HEALTHCARE · MEDICAL DISTRIBUTION · China

Akso Health Group ADR is a leading entity in the healthcare sector, focused on delivering innovative medical solutions and integrated patient care services. With a specialization in advanced health technologies, the company is well-positioned to tap into growth opportunities in telehealth and personalized medicine, bolstered by a strong commitment to research and development. Its robust business model and dedication to quality, supported by a skilled team of professionals, make Akso Health Group an appealing investment for institutional investors aiming to navigate the transformative landscape of healthcare.

Visit Website →

Synergy CHC Corp. Common Stock

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Synergy CHC Corp. The company is headquartered in Westbrook, Maine.

Want to dig deeper into these stocks?